Aegerion Pharmaceuticals (AEGR)

Add to Watchlists
Create an Alert
34.21 +1.43  +4.36% NASDAQ Oct 30, 8:00PM BATS Real time Currency in USD
View Full Chart
AEGR Price Chart
View All Events

AEGR Events

Date Type Description
10/30/2014 17:00 EDT Misc Q3 2014 Aegerion Pharmaceuticals Earnings Conference Call
10/30/2014 Earnings Q3 2014 Aegerion Pharmaceuticals Earnings Results
07/29/2014 17:00 EDT Misc Aegerion Pharmaceuticals Inc 2014 Second Quarter Earnings Conference Call
07/29/2014 Earnings Aegerion Pharmaceuticals Announces Second-Quarter 2014 Financial Results
06/25/2014 Misc Annual General Meeting for Aegerion Pharmaceuticals Inc
05/06/2014 17:00 EDT Misc Aegerion Pharmaceuticals Inc Q1 2014 Earnings Conference Call
05/06/2014 Earnings Aegerion Pharmaceuticals Inc Q1 2014 Earnings Results
02/26/2014 08:30 EST Misc Aegerion Pharmaceuticals, Inc. Earnings Conference Call
02/26/2014 Earnings Aegerion Pharmaceuticals, Inc. Earnings Results
01/09/2014 Misc Aegerion Pharmaceuticals Reports Preliminary 2013 Net Product Sales, Its Outlook for 2014 and Other Business Updates
View All Performance Charts

AEGR Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Aegerion Pharmaceuticals is down 59.87% over the last year vs S&P 500 Total Return up 14.92%, Amgen up 40.97%, and Sequenom up 32.86%.

Get Quote for

PDF Report for AEGR

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download AEGR Pro Report PDF

Portfolio Strategies Featuring AEGR

Did Aegerion Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

AEGR Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website:
  • IR Website:
  • HQ Country: United States
  • HQ State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: December 31, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: June 30, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Aegerion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company currently operates in one business segment focusing on the development and commercialization of its product, lomitapide.

AEGR Excel Add-In Codes

  • Name: =YCI("AEGR","name")
  • Description: =YCI("AEGR","description")
  • Sector: =YCI("AEGR","sector")
  • Industry: =YCI("AEGR","industry")
  • Est. Current Fiscal Year End: =YCI("AEGR","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.


You've hit the 10 page limit on YCharts.

Experience the power of YCharts Professional.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.


Start your free 14 Day Trial.

{{}} No credit card required.

Already a subscriber? Sign in.